北美生物信息学市场 – 2029 年行业趋势和预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

北美生物信息学市场 – 2029 年行业趋势和预测

  • Medical Devices
  • Published Report
  • Aug 2022
  • North America
  • 350 页面
  • 桌子數: 140
  • 图号: 48

North America Bioinformatics Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2015 –0
Diagram Market Size (Base Year)
USD MILLION
Diagram Market Size (Forecast Year)
USD MILLION
Diagram CAGR
%
Diagram Major Markets Players
  • Thermo Fisher Scientific
  • Illumina
  • Agilent Technologies
  • QIAGEN SOPHiA GENETICS
  • BGI

>北美生物信息学市场,按类型(知识管理工具、生物信息学软件和服务)、部门(医学生物技术、学术、动物生物技术、农业生物技术、环境生物技术、法医生物技术等)、应用(基因组学和药物开发、蛋白质组学、进化研究、农业研究、兽医学、代谢组学、转录组学等)、购买模式(团购和个人购买)、方法(基因组学和蛋白质组学)最终用户(研究和学术机构、临床研究组织、生物技术和制药公司、研究实验室、医院等)划分 - 行业趋势和预测到 2029 年。

生物信息学市场

北美生物信息学市场分析与洞察

推动生物信息学市场增长的因素包括:每个碱基的基因测序成本较低、对生物信息学的需求不断增长、主要市场参与者提供的产品组合广泛、生物信息学在个性化医疗中的应用以及公共和私营部门对生物信息学的资助增加。然而,预计会限制市场增长的因素包括仪器成本的上升、临床生物信息学分析的难度以及生物信息学的网络安全。

生物信息学市场

生物信息学市场

另一方面,市场参与者的战略举措、产品开发、生物信息学技术的进步以及医疗保健支出的增加可能为生物信息学市场的增长提供机会。然而,对熟练专业知识的需求、在临床实验室实施生物信息学技术的挑战以及监管部门的批准可能会给生物信息学市场带来挑战。最近出现了与全球生物信息学市场相关的发展。

药物开发和设计中对生物信息学应用的需求不断增长,预计将推动北美市场的增长。Data Bridge Market Research 分析称,在 2022 年至 2029 年的预测期内,北美生物信息学市场将以 21.8% 的复合年增长率增长。

报告指标

细节

预测期

2022 至 2029 年

基准年

2021

历史岁月

2020(可定制至 2019 - 2014)

定量单位

收入(百万美元),定价(美元)

涵盖的领域

按类型(知识管理工具、生物信息学软件和服务)、部门(医学生物技术、学术、动物生物技术、农业生物技术、环境生物技术、法医生物技术等)、应用(基因组学和药物开发、蛋白质组学、进化研究、农业研究、兽医学、代谢组学、转录组学等)、购买模式(团购和个人购买)、方法(基因组学和蛋白质组学)最终用户(研究和学术机构、临床研究组织、生物技术和制药公司、研究实验室、医院等)

覆盖国家

美国、加拿大和墨西哥

涵盖的市场参与者

Thermo Fisher Scientific Inc.、Illumina, Inc.、Agilent Technologies, Inc.、QIAGEN、SOPHiA GENETICS.、BGI、Eurofins Scientific、Water Corporation、Partek Incorporated、DNASTAR、Dassault Systèmes、Bayer AG、DNANEXUS, INC.、PerkinElmer Inc.、Seven Bridges Genomics、Quest Diagnostics Incorporated.、AstridBio Technologies Inc.、BioBam、GenoFAB, Inc. 等等

市场定义

生物信息学结合了计算机编程、大数据和分子生物学,使科学家能够理解和识别生物数据中的模式。它在研究基因组和 DNA 测序方面特别有用,因为它允许科学家组织大量数据。

从遗传学到毒理学再到真菌学和放射生物学,生物学有许多分支学科可供研究。在众多分支学科中,生物信息学是最有趣的领域之一,它能让你识别、评估、存储和检索生物信息。作为一个跨学科的研究领域,它结合了计算机科学、统计学和生物学的各种应用,开发用于理解生物数据的软件应用程序,如 DNA 测序、蛋白质分析、进化遗传学等。

在不久的将来,与药物发现的生物信息学相关的重要决策将由那些不仅了解生物学,而且还能使用生物信息学工具及其发布的知识来制定假设和确定质量目标的个人来做出。

北美生物信息学市场动态

驱动程序

  • 降低每个碱基的基因测序成本

口腔健康是维持牙龈、牙齿和口腔面部系统健康的最重要方面之一,口腔系统允许说话、咀嚼和微笑。根据世界卫生组织 2020 年 3 月 25 日的报告,全球约有 23 亿人患有恒牙龋齿,其中约有 5.3 亿儿童患有乳牙龋齿。在北美,牙周病在所有年龄组中的患病率很高。因此,由于牙周牙科疾病的增加,口内扫描仪的普及和使用预计将推动市场的增长。

  • 对生物信息学的需求日益增长

随着以基因组学为重点的药理学在治疗各种慢性疾病(尤其是癌症)方面发挥着越来越重要的作用,新一代测序 (NGS) 正在发展成为一种强大的工具,可以更深入、更准确地了解单个肿瘤和特定受体的分子基础。信息学在涉及学习编程的生物学家、计算机程序员、数学家或学习生物学基础知识的数据库管理员的生物学研究中至关重要。

机会

  • 近年产品开发

生物信息学市场临床应用的增长曲线呈上升趋势,因为现有应用正在获得发展势头,而新应用正在找到立足点。过去几年的产品开发帮助市场规模增长。这也表明监管机构支持允许这些产品进入市场。

例如-

  • 2021 年 6 月,安捷伦科技公司发布了一种名为 Sure Select Human All Exon V8 的新外显子组设计,该设计提供 Refuses、CCDS 和 GENCODE 的蛋白质编码区域的特定内容和当前覆盖范围。此外,它还包括难以捕获的外显子和 TERT 启动子,而这些外显子被竞争外显子组忽略

近年来的产品开发显示了这些技术的潜力,在这个市场工作的公司正试图在市场上推出更先进的产品,预计这将为预测期内的市场增长创造有利可图的机会。

  • 市场参与者的战略举措

由于研发水平的提高以及生物信息学服务市场的增长以及对创新药物的需求,市场对生物信息学的需求正在增加。因此,顶级市场参与者实施了一项新战略,通过开发新产品并与其他市场参与者合作来改善业务运营和盈利能力。

例如-

  • 2020 年 1 月,Charles River 与 FiOS Genomics 建立战略联盟,以获取生物信息学、统计学和生物学方面的知识,以帮助收集和分析与药物开发相关的高维、多变量数据集,例如微阵列、下一代测序 (NGS)、蛋白质组学、代谢组学和表观遗传学,以及相关的元数据

市场参与者的这些战略举措,包括收购、会议和重点细分产品发布,正在帮助他们发展和改善公司的产品组合,最终带来更多收入。因此,市场参与者的这些战略举措可能有望成为推动市场增长的机会。

限制/挑战

  • 临床生物信息学分析的难点

大数据分析的潜力尚未得到充分开发,这一话题随着大量下一代数据集的产生而愈演愈烈,这些数据集旨在解答人类疾病生物学方面的长期问题。尽管这些方法可能是揭示新生物学见解的有力手段,但目前有几个重大挑战阻碍了利用大数据的力量。典型的挑战包括有效评估分析软件工具、使用混合并行计算 (HPC) 并行化和加速技术加快整个过程、自动化策略的进步、数据存储替代方案,以及最终开发新方法以充分利用多种实验条件下的结果。

  • 在临床实验室实施生物信息学技术的挑战

生物信息学技术可以执行大量复杂的生物数据分析。这种能力同时促进了组织和分析生物数据的计算工具,有助于改善诊断筛查。由于数据的范围、数量和医疗技术后果,这些强大的技术在临床实验室中的应用带来了挑战。

在临床实验室实施下一代测序的各种挑战如下:

  • 问题最容易出现的领域之一往往是最容易被忽视的:“样本质量”。尽管平台通常使用精心挑选的样本进行测试和比较(例如来自瓶中基因组联盟的参考材料),但现实世界的样本往往更具挑战性,因此对需求的增长构成了挑战
  • 对于在这个市场工作的仪器来说,高周转时间也是一个主要挑战

COVID-19 对北美生物信息学市场的影响

在疫情期间,北方生物信息学部门专注于将生物学和信息技术相结合。该行业的核心是生物数据,使用 IT 技术对其进行分析和转换。生物信息学在为许多科学研究领域提供必要支持方面一直具有巨大潜力。生物信息学可以提供的工具使科学家能够掌握更大的数据集并对其进行挖掘和分析,以发现可能导致关键发现的关键信息。近年来,遗传学和基因组一直是生物信息学的主要关注点,包括比较基因组学、DNA 微阵列和功能基因组学。

最新动态

  • 2022 年 3 月,赛默飞世尔科技公司推出了用于临床实验室的 CE-IVD 标记的下一代测序 (NGS) 仪器。CE-IVD 标记的下一代测序仪器用于在单个仪器上进行诊断测试和临床研究。该仪器的推出导致产品系列中增加了一款新产品,并分销了 NGS 仪器,预计将增加产品收入。

北美生物信息学市场范围

北美生物信息学市场分为六个部分:类型、行业、应用、购买模式、基因组学和最终用户。这些部分之间的增长将帮助您分析行业中增长微弱的部分,并为用户提供有价值的市场概览和市场洞察,帮助他们做出战略决策,以确定核心市场应用。

类型

  • 知识管理工具
  • 生物信息学软件
  • 服务

根据类型,北美生物信息学市场分为知识管理工具、生物信息学软件和服务。

部门

  • 医药生物技术
  • 学术
  • 动物生物技术
  • 农业生物技术
  • 环境生物技术
  • 法医生物技术
  • 其他的

根据行业,北美生物信息学市场分为医学生物技术、学术、动物生物技术、农业生物技术、环境生物技术、法医生物技术等。

应用

  • 基因组学和药物开发
  • 蛋白质组学
  • 进化研究
  • 农业研究
  • 兽医学
  • 代谢组学
  • 转录组学
  • 其他的

根据应用,北美生物信息学市场分为基因组学和药物开发、蛋白质组学、进化研究、农业研究、兽医学、代谢组学、转录组学等。

购买方式

  • 团购
  • 个人购买

根据购买模式,北美生物信息学市场分为团购和个人购买。

方法

  • 基因组学
  • 蛋白质组学

根据方法,北美生物信息学市场分为基因组学和蛋白质组学。

最终用户

  • 研究与学术机构
  • 临床研究组织
  • 生物科技和制药公司
  • 研究实验室
  • 医院
  • 其他的

生物信息学市场

根据最终用户,北美生物信息学市场分为研究和学术机构、临床研究组织、生物技术和制药公司、研究实验室、医院等。

管道分析

北美生物信息学市场区域分析/见解

对北美生物信息学市场进行了分析,并按地区、类型、部门、应用、购买模式、基因组学和最终用户提供了市场规模洞察和趋势。如上所述。

北美生物信息学市场报告涵盖的国家包括美国、加拿大和新墨西哥州。由于牙周病发病率上升、医疗旅游增长、生物信息学技术创新增长以及研发活动增加,美国预计将主导市场。

报告的国家部分还提供了影响单个市场因素和国内市场法规变化,这些因素和法规变化会影响市场的当前和未来趋势。新销售、替代销售、国家人口统计、疾病流行病学和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外,在对国家数据进行预测分析时,还考虑了品牌的存在和可用性以及由于来自本地和国内品牌的激烈或稀缺竞争对销售渠道的影响而面临的挑战。

竞争格局和北美生物信息学市场份额分析

北美生物信息学市场竞争格局提供了有关竞争对手的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、北美业务、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度以及应用主导地位。以上提供的数据点仅与公司对北美生物信息学市场的关注有关。

北美生物信息学市场的一些主要参与者包括赛默飞世尔科技公司 (Thermo Fisher Scientific Inc.)、Illumina 公司、安捷伦科技公司 (Agilent Technologies, Inc.)、QIAGEN、SOPHiA GENETICS、BGI、Eurofins Scientific、Water Corporation、Partek Incorporated、DNASTAR、Dassault Systèmes、拜耳公司 (Bayer AG)、DNANEXUS 公司、PerkinElmer 公司、Seven Bridges Genomics、Quest Diagnostics Incorporated、AstridBio Technologies 公司、BioBam、GenoFAB 公司等。


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

目录

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE NORTH AMERICA BIOINFORMATICS MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATION

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHIC SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 RESEARCH METHODOLOGY

2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.7 MULTIVARIATE MODELLING

2.8 TYPE SEGMENT LIFELINE CURVE

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 MARKET APPLICATION COVERAGE GRID

2.12 THE CATEGORY VS TIME GRID

2.13 SECONDARY SOURCES

2.14 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL

4.2 PORTER'S FIVE FORCES MODEL

5 REGULATIONS OF THE NORTH AMERICA BIOINFORMATICS MARKET

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 DECREASE IN THE COST OF GENETIC SEQUENCING PER BASE

6.1.2 GROWING NEED FOR BIOINFORMATICS

6.1.3 WIDE PRODUCT PORTFOLIO OFFERED BY MAJOR PLAYERS

6.1.4 USE OF BIOINFORMATICS IN PERSONALIZED MEDICINE

6.1.5 INCREASING PUBLIC-PRIVATE SECTOR FUNDING FOR BIOINFORMATICS

6.2 RESTRAINTS

6.2.1 HIGH COST OF INSTRUMENTATION

6.2.2 DIFFICULTY IN CLINICAL BIOINFORMATICS ANALYSIS

6.2.3 CYBER SECURITY CONCERNS IN BIOINFORMATICS

6.3 OPPORTUNITIES

6.3.1 STRATEGIC INITIATIVES BY THE KEY MARKET PLAYER

6.3.2 PRODUCT DEVELOPMENT IN RECENT YEARS

6.3.3 ADVANCEMENT IN BIOINFORMATICS TECHNOLOGY

6.4 CHALLENGES

6.4.1 LACK OF SKILLED PROFESSIONALS TO PERFORM BIOINFORMATICS TECHNOLOGY

6.4.2 CHALLENGES TO IMPLEMENTING BIOINFORMATICS TECHNOLOGY IN THE CLINICAL LABS

7 NORTH AMERICA BIOINFORMATICS MARKET, BY TYPE

7.1 OVERVIEW

7.2 SERVICES

7.2.1 DIAGNOSTICS CONSULTATION

7.2.2 DATA ANALYSIS

7.2.2.1 STRUCTURAL

7.2.2.2 FUNCTIONAL

7.3 BIOINFORMATICS SOFTWARE

7.3.1 INFORMATICS INFRASTRUCTURE AND PIPELINE SETUP

7.3.2 SAMPLE AND EXPERIMENT MANAGEMENT

7.3.3 SEQUENCING DATA ANALYSIS

7.3.3.1 SEQUENCE ANALYSIS PLATFORM

7.3.3.2 SEQUENCE ALIGNMENT PLATFORM

7.3.3.3 SEQUENCE MANIPULATION PLATFORM

7.3.3.4 STRUCTURAL ANALYSIS PLATFORM

7.3.3.5 OTHERS

7.3.4 BIOLOGICAL DATA INTERPRETATION

7.3.5 SPECIALIZED BIOINFORMATICS APPLICATIONS

7.3.5.1 SINGLE CELL GENE EXPRESSION

7.3.5.2 GENE EXPRESSION

7.3.5.3 VARIANT DETECTION

7.3.5.4 CNV ANALYSIS

7.3.5.5 METAGENOMICS

7.3.5.6 METHYLATION

7.3.5.7 CHIP-SEQ

7.3.5.8 NON-CODING RNA EXPRESSION

7.3.5.9 OTHERS

7.3.6 OTHERS

7.4 KNOWLEDGE MANAGEMENT TOOLS

7.4.1 GENERALIZED KNOWLEDGE MANAGEMENT TOOLS

7.4.2 SPECIALIZED KNOWLEDGE MANAGEMENT TOOLS

8 NORTH AMERICA BIOINFORMATICS MARKET, BY SECTOR

8.1 OVERVIEW

8.2 MEDICAL BIOTECHNOLOGY

8.3 ACADEMICS

8.4 ANIMAL BIOTECHNOLOGY

8.5 AGRICULTURAL BIOTECHNOLOGY

8.6 ENVIRONMENTAL BIOTECHNOLOGY

8.7 FORENSIC BIOTECHNOLOGY

8.8 OTHERS

9 NORTH AMERICA BIOINFORMATICS MARKET, BY APPLICATION

9.1 OVERVIEW

9.2 GENOMICS & DRUG DEVELOPMENT

9.2.1 SERVICES

9.2.2 SEQUENCING PLATFORMS

9.2.3 KNOWLEDGE MANAGEMENT TOOLS

9.2.4 GENOMICS & DRUG DEVELOPMENT BY TYPE

9.2.4.1 PREVENTIVE MEDICINE

9.2.4.2 MOLECULAR MEDICINE

9.2.4.3 PERSONALIZED MEDICINE

9.2.4.4 CHEMOINFORMATICS AND DRUG DESIGN

9.2.4.5 ANTIBIOTIC RESISTANCE

9.3 PROTEOMICS

9.3.1 SERVICES

9.3.2 SERVICES SEQUENCING PLATFORMS

9.3.3 KNOWLEDGE MANAGEMENT TOOLS

9.4 AGRICULTURAL STUDIES

9.4.1 SERVICES

9.4.2 SERVICES SEQUENCING PLATFORMS

9.4.3 KNOWLEDGE MANAGEMENT TOOLS

9.5 TRANSCRIPTOMICS

9.5.1 SERVICES

9.5.2 SERVICES SEQUENCING PLATFORMS

9.5.3 KNOWLEDGE MANAGEMENT TOOLS

9.6 METABOLOMICS

9.6.1 SERVICES

9.6.2 SERVICES SEQUENCING PLATFORMS

9.6.3 KNOWLEDGE MANAGEMENT TOOLS

9.7 EVOLUTIONARY STUDIES

9.7.1 SERVICES

9.7.2 SERVICES SEQUENCING PLATFORMS

9.7.3 KNOWLEDGE MANAGEMENT TOOLS

9.8 VETERINARY SCIENCE

9.8.1 SERVICES

9.8.2 SERVICES SEQUENCING PLATFORMS

9.8.3 KNOWLEDGE MANAGEMENT TOOLS

9.9 OTHERS

9.9.1 SERVICES

9.9.2 SERVICES SEQUENCING PLATFORMS

9.9.3 KNOWLEDGE MANAGEMENT TOOLS

10 NORTH AMERICA BIOINFORMATICS MARKET, BY PURCHASE MODE

10.1 OVERVIEW

10.2 GROUP PURCHASE

10.3 INDIVIDUAL PURCHASE

11 NORTH AMERICA BIOINFORMATICS MARKET, BY METHOD

11.1 OVERVIEW

11.2 GENOMICS

11.2.1 DNA

11.2.2 RNA

11.3 PROTEOMICS

12 NORTH AMERICA BIOINFORMATICS MARKET, BY END USER

12.1 OVERVIEW

12.2 RESEARCH AND ACADEMIC INSTITUTES

12.3 CLINICAL RESEARCH ORGANIZATION

12.4 BIOTECH AND PHARMACEUTICAL COMPANIES

12.5 RESEARCH LABORATORIES

12.6 HOSPITALS

12.7 OTHERS

13 NORTH AMERICA BIOINFORMATICS MARKET, BY REGION

13.1 NORTH AMERICA

13.1.1 U.S.

13.1.2 CANADA

13.1.3 MEXICO

14 NORTH AMERICA BIOINFORMATICS MARKET: COMPANY LANDSCAPE

14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

15 SWOT ANALYSIS

16 COMPANY PROFILE

16.1 BAYER AG

16.1.1 COMPANY SNAPSHOT

16.1.2 REVENUE ANALYSIS

16.1.3 COMPANY SHARE ANALYSIS

16.1.4 PRODUCT PORTFOLIO

16.1.5 RECENT DEVELOPMENTS

16.2 THERMO FISHER SCIENTIFIC INC

16.2.1 COMPANY SNAPSHOT

16.2.2 REVENUE ANALYSIS

16.2.3 COMPANY SHARE ANALYSIS

16.2.4 PRODUCT PORTFOLIO

16.2.5 RECENT DEVELOPMENTS

16.3 EUROFINS SCIENTIFIC

16.3.1 COMPANY SNAPSHOT

16.3.2 REVENUE ANALYSIS

16.3.3 COMPANY SHARE ANALYSIS

16.3.4 PRODUCT PORTFOLIO

16.3.5 RECENT DEVELOPMENTS

16.4 DASSAULT SYSTÈMES

16.4.1 COMPANY SNAPSHOT

16.4.2 REVENUE ANALYSIS

16.4.3 COMPANY SHARE ANALYSIS

16.4.4 PRODUCT PORTFOLIO

16.4.5 RECENT DEVELOPMENTS

16.5 AGILENT TECHNOLOGIES, INC

16.5.1 COMPANY SNAPSHOT

16.5.2 REVENUE ANALYSIS

16.5.3 COMPANY SHARE ANALYSIS

16.5.4 PRODUCT PORTFOLIO

16.5.5 RECENT DEVELOPMENTS

16.6 ASTRIDBIO TECHNOLOGIES INC.

16.6.1 COMPANY SNAPSHOT

16.6.2 PRODUCT PORTFOLIO

16.6.3 RECENT DEVELOPMENTS

16.7 BGI (A SUBSIDIARY OF BGI GROUP)

16.7.1 COMPANY SNAPSHOT

16.7.2 PRODUCT PORTFOLIO

16.7.3 RECENT DEVELOPMENTS

16.8 BIOBAM

16.8.1 COMPANY SNAPSHOT

16.8.2 PRODUCT PORTFOLIO

16.8.3 RECENT DEVELOPMENTS

16.9 DNANEXUS INC.

16.9.1 COMPANY SNAPSHOT

16.9.2 PRODUCT PORTFOLIO

16.9.3 RECENT DEVELOPMENTS

16.1 DNASTAR

16.10.1 COMPANY SNAPSHOT

16.10.2 PRODUCT PORTFOLIO

16.10.3 RECENT DEVELOPMENTS

16.11 GENOFAB, INC

16.11.1 COMPANY SNAPSHOT

16.11.2 PRODUCT PORTFOLIO

16.11.3 RECENT DEVELOPMENTS

16.12 ILLUMINA, INC

16.12.1 COMPANY SNAPSHOT

16.12.2 REVENUE ANALYSIS

16.12.3 PRODUCT PORTFOLIO

16.12.4 RECENT DEVELOPMENTS

16.13 PARTEK INCORPORATED

16.13.1 COMPANY SNAPSHOT

16.13.2 PRODUCT PORTFOLIO

16.13.3 RECENT DEVELOPMENTS

16.14 PERKINELMER INC.

16.14.1 COMPANY SNAPSHOT

16.14.2 PRODUCT PORTFOLIO

16.14.3 RECENT DEVELOPMENTS

16.15 QIAGEN

16.15.1 COMPANY SNAPSHOT

16.15.2 REVENUE ANALYSIS

16.15.3 PRODUCT PORTFOLIO

16.15.4 RECENT DEVELOPMENTS

16.16 QUEST DIAGNOSTICS INCORPORATED (2021)

16.16.1 COMPANY SNAPSHOT

16.16.2 REVENUE ANALYSIS

16.16.3 PRODUCT PORTFOLIO

16.16.4 RECENT DEVELOPMENTS

16.17 SEVEN BRIDGES GENOMICS

16.17.1 COMPANY SNAPSHOT

16.17.2 PRODUCT PORTFOLIO

16.17.3 RECENT DEVELOPMENTS

16.18 SOPHIA GENETICS

16.18.1 COMPANY SNAPSHOT

16.18.2 REVENUE ANALYSIS

16.18.3 PRODUCT PORTFOLIO

16.18.4 RECENT DEVELOPMENTS

16.19 STRAND LIFE SCIENCES

16.19.1 COMPANY SNAPSHOT

16.19.2 PRODUCT PORTFOLIO

16.19.3 RECENT DEVELOPMENTS

16.2 WATERS CORPORATION

16.20.1 COMPANY SNAPSHOT

16.20.2 PRODUCT PORTFOLIO

16.20.3 RECENT DEVELOPMENTS

17 QUESTIONNAIRE

18 RELATED REPORTS

表格列表

TABLE 1 BIOINFORMATICSCOST PER SAMPLE

TABLE 2 NORTH AMERICA BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 3 NORTH AMERICA SERVICES IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 4 NORTH AMERICA SERVICES IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 5 NORTH AMERICA DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 6 NORTH AMERICA BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 7 NORTH AMERICA BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 8 NORTH AMERICA SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 9 NORTH AMERICA SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 10 NORTH AMERICA KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 11 NORTH AMERICA KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 12 NORTH AMERICA BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 13 NORTH AMERICA MEDICAL BIOTECHNOLOGY IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 14 NORTH AMERICA ACADEMICS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 15 NORTH AMERICA ANIMAL TECHNOLOGY IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 16 NORTH AMERICA AGRICULTURAL BIOTECHNOLOGY IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 17 NORTH AMERICA ENVIRONMENTAL BIOTECHNOLOGY IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 18 NORTH AMERICA FORENSIC BIOTECHNOLOGY IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 19 NORTH AMERICA OTHERS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 20 NORTH AMERICA BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 21 NORTH AMERICA GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 22 NORTH AMERICA GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 23 NORTH AMERICA GENOMICS & DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 24 NORTH AMERICA PROTEOMICS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 25 NORTH AMERICA PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 26 NORTH AMERICA AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 27 NORTH AMERICA AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 28 NORTH AMERICA TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 29 NORTH AMERICA TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 30 NORTH AMERICA METABOLOMICS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 31 NORTH AMERICA METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 32 NORTH AMERICA EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 33 NORTH AMERICA EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 34 NORTH AMERICA VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 35 NORTH AMERICA VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 36 NORTH AMERICA OTHERS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 37 NORTH AMERICA OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 38 NORTH AMERICA BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)

TABLE 39 NORTH AMERICA GROUP PURCHASE IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 40 NORTH AMERICA INDIVIDUAL PURCHASE IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 41 NORTH AMERICA BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 42 NORTH AMERICA GENOMICS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 43 NORTH AMERICA GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 44 NORTH AMERICA PROTEOMICS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 45 NORTH AMERICA BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 46 NORTH AMERICA RESEARCH AND ACADEMIC INSTITUTES IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 47 NORTH AMERICA CLINICAL RESEARCH ORGANIZATION IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 48 NORTH AMERICA BIOTECH AND PHARMACEUTICAL COMPANIES IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 49 NORTH AMERICA RESEARCH LABORATORIES IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 50 NORTH AMERICA HOSPITALS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 51 NORTH AMERICA OTHERS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 52 NORTH AMERICA BIOINFORMATICS MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 53 NORTH AMERICA BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 54 NORTH AMERICA SERVICES IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 55 NORTH AMERICA DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 56 NORTH AMERICA BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 57 NORTH AMERICA SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 58 NORTH AMERICA SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 59 NORTH AMERICA KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 60 NORTH AMERICA BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 61 NORTH AMERICA BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 62 NORTH AMERICA GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 63 NORTH AMERICA GENOMICS & DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 64 NORTH AMERICA PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 65 NORTH AMERICA AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 66 NORTH AMERICA AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 67 NORTH AMERICA METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 68 NORTH AMERICA EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 69 NORTH AMERICA VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 70 NORTH AMERICA OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 71 NORTH AMERICA BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)

TABLE 72 NORTH AMERICA BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 73 NORTH AMERICA GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 74 NORTH AMERICA. BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 75 U.S. BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 76 U.S. SERVICES IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 77 U.S. DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 78 U.S. BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 79 U.S. SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 80 U.S. SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 81 U.S. KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 82 U.S. BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 83 U.S. BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 84 U.S. GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 85 U.S. GENOMICS & DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 86 U.S. PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 87 U.S. AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 88 U.S. TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 89 U.S. METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 90 U.S. EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 91 U.S. VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 92 U.S. OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 93 U.S. BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)

TABLE 94 U.S. BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 95 U.S GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 96 U.S. BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 97 CANADA BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 98 CANADA SERVICES IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 99 CANADA DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 100 CANADA BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 101 CANADA SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 102 CANADA SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 103 CANADA KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 104 CANADA BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 105 CANADA BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 106 CANADA GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 107 CANADA GENOMICS & DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 108 CANADA PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 109 CANADA AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 110 CANADA TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 111 CANADA METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 112 CANADA EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 113 CANADA VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 114 CANADA OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 115 CANADA BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)

TABLE 116 CANADA BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 117 CANADA GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 118 CANADA BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 119 MEXICO BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 120 MEXICO SERVICES IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 121 MEXICO DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 122 MEXICO BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 123 MEXICO SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 124 MEXICO SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 125 MEXICO KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 126 MEXICO BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)

TABLE 127 MEXICO BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 128 MEXICO GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 129 MEXICO GENOMICS & DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 130 MEXICO PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 131 MEXICO AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 132 MEXICO TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 133 MEXICO METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 134 MEXICO EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 135 MEXICO VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 136 MEXICO OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 137 MEXICO BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)

TABLE 138 MEXICO BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 139 MEXICO GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 140 MEXICO BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)

图片列表

FIGURE 1 NORTH AMERICA BIOINFORMATICS MARKET: SEGMENTATION

FIGURE 2 NORTH AMERICA BIOINFORMATICS MARKET: GEOGRAPHIC SCOPE

FIGURE 3 NORTH AMERICA BIOINFORMATICS MARKET: DATA TRIANGULATION

FIGURE 4 NORTH AMERICA BIOINFORMATICS MARKET: SNAPSHOT

FIGURE 5 NORTH AMERICA BIOINFORMATICS MARKET: BOTTOM-UP APPROACH

FIGURE 6 NORTH AMERICA BIOINFORMATICS MARKET: TOP-DOWN APPROACH

FIGURE 7 NORTH AMERICA BIOINFORMATICS MARKET: INTERVIEWS BY REGION AND DESIGNATION

FIGURE 8 NORTH AMERICA BIOINFORMATICS MARKET: DBMR MARKET POSITION GRID

FIGURE 9 NORTH AMERICA BIOINFORMATICS MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 NORTH AMERICA BIOINFORMATICS MARKET: APPLICATION COVERAGE GRID

FIGURE 11 NORTH AMERICA BIOINFORMATICS MARKET: THE CATEGORY VS TIME GRID

FIGURE 12 NORTH AMERICA BIOINFORMATICS MARKET SEGMENTATION

FIGURE 13 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE NORTH AMERICA DENTAL LABMARKET AND IS ESTIMATED TO BE GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 14 GROWING APPLICATIONS OF BIOINFORMATICS AND LOW COST OF BIOINFORMATICS SEQUENCING ARE EXPECTED TO DRIVE THE MARKET FOR NORTH AMERICA BIOINFORMATICS MARKET IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 15 SERVICES SEGMENT ARE EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA BIOINFORMATICS MARKET IN 2019 & 2026

FIGURE 16 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA BIOINFORMATICS MARKET

FIGURE 17 DECREASE IN COST OF PER BASE SEQUENCING

FIGURE 18 GROWING NEED FOR BIOINFORMATICS IN VITAL APPLICATIONS

FIGURE 19 NORTH AMERICA BIOINFORMATICS MARKET: BY TYPE, 2021

FIGURE 20 NORTH AMERICA BIOINFORMATICS MARKET: BY TYPE, 2022-2029 (USD MILLION)

FIGURE 21 NORTH AMERICA BIOINFORMATICS MARKET: BY TYPE, CAGR (2022-2029)

FIGURE 22 NORTH AMERICA BIOINFORMATICS MARKET: BY TYPE, LIFELINE CURVE

FIGURE 23 NORTH AMERICA BIOINFORMATICS MARKET: BY SECTOR, 2021

FIGURE 24 NORTH AMERICA BIOINFORMATICS MARKET: BY SECTOR, 2022-2029 (USD MILLION)

FIGURE 25 NORTH AMERICA BIOINFORMATICS MARKET: BY SECTOR, CAGR (2022-2029)

FIGURE 26 NORTH AMERICA BIOINFORMATICS MARKET: BY SECTOR, LIFELINE CURVE

FIGURE 27 NORTH AMERICA BIOINFORMATICS MARKET: BY APPLICATION, 2021

FIGURE 28 NORTH AMERICA BIOINFORMATICS MARKET: BY APPLICATION, 2022-2029 (USD MILLION)

FIGURE 29 NORTH AMERICA BIOINFORMATICS MARKET: BY APPLICATION, CAGR (2022-2029)

FIGURE 30 NORTH AMERICA BIOINFORMATICS MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 31 NORTH AMERICA BIOINFORMATICS MARKET: BY PURCHASE MODE, 2021

FIGURE 32 NORTH AMERICA BIOINFORMATICS MARKET: BY PURCHASE MODE, 2022-2029 (USD MILLION)

FIGURE 33 NORTH AMERICA BIOINFORMATICS MARKET: BY PURCHASE MODE, CAGR (2022-2029)

FIGURE 34 NORTH AMERICA BIOINFORMATICS MARKET: BY PURCHASE MODE, LIFELINE CURVE

FIGURE 35 NORTH AMERICA BIOINFORMATICS MARKET: BY METHOD, 2021

FIGURE 36 NORTH AMERICA BIOINFORMATICS MARKET: BY METHOD, 2022-2029 (USD MILLION)

FIGURE 37 NORTH AMERICA BIOINFORMATICS MARKET: BY METHOD, CAGR (2022-2029)

FIGURE 38 NORTH AMERICA BIOINFORMATICS MARKET: BY METHOD, LIFELINE CURVE

FIGURE 39 NORTH AMERICA BIOINFORMATICS MARKET: BY END USER, 2021

FIGURE 40 NORTH AMERICA BIOINFORMATICS MARKET: BY END USER, 2022-2029 (USD MILLION)

FIGURE 41 NORTH AMERICA BIOINFORMATICS MARKET: BY END USER, CAGR (2022-2029)

FIGURE 42 NORTH AMERICA BIOINFORMATICS MARKET: BY END USER, LIFELINE CURVE

FIGURE 43 NORTH AMERICA BIOINFORMATICS MARKET: SNAPSHOT (2021)

FIGURE 44 NORTH AMERICA BIOINFORMATICS MARKET: BY COUNTRY (2021)

FIGURE 45 NORTH AMERICA BIOINFORMATICS MARKET: BY COUNTRY (2022 & 2029)

FIGURE 46 NORTH AMERICA BIOINFORMATICS MARKET: BY COUNTRY (2021 & 2029)

FIGURE 47 NORTH AMERICA BIOINFORMATICS MARKET: BY TYPE (2022-2029)

FIGURE 48 NORTH AMERICA BIOINFORMATICS MARKET: COMPANY SHARE 2021 (%)

查看详细信息 Right Arrow

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The North America Bioinformatics Market will grow at a CAGR of 21.8% by 2029.
The significant factors flourishing the growth of the North America Bioinformatics Market are Decrease in The Cost of Genetic Sequencing Per Base, and Growing Need for Bioinformatics.
The major players operating in the North America Bioinformatics Market are Thermo Fisher Scientific Inc., Illumina, Inc., Agilent Technologies, Inc., QIAGEN, SOPHiA GENETICS., BGI, Eurofins Scientific, Water Corporation, Partek Incorporated, DNASTAR, Dassault Systèmes, Bayer AG, DNANEXUS, INC., PerkinElmer Inc., Seven Bridges Genomics, Quest Diagnostics Incorporated., AstridBio Technologies Inc., BioBam, GenoFAB, Inc. Among others.
The major countries covered in the North America Bioinformatics Market are The U.S., Canada, and Mexico.